SUCLG2P2 and colonic neoplasm: The pseudogene SUCLG2P2 along with two other genes (SUCLG2 and ATIC) were introduced as potential prognostic markers for colon cancer, aiding in predicting patient outcomes and tailoring treatment strategies [24].